Citations

Clear

32 citation(s) found for "Eldrige, Jason".

Ultrasound-Guided Gluteal Fascial Plane Block for the Treatment of Chronic Refractory Greater Trochanteric Pain Syndrome — Technique Description and Anatomical Correlation Study
Ferreira‐Dos‐Santos, Guilherme , Hurdle, Mark Friedrich B., Tran, John , Eldrige, Jason S. , Clendenen, Steven R. , Agur, Anne Maria Reet

Mayo Clinic

Pain Medicine | April 26, 2022 | Volume: 23 | Issue: 11 | Pages: 1875-1881

10.1093/pm/pnac071 | PMID 35511153 Get It

Abstract Introduction Greater trochanteric pain syndrome may often mimic pain generated from other sources. However, it is most commonly caused by gluteus medius and gluteus minimus tendinopathy or tear. The purpose of this technical report was to: 1) describe the ultrasound-guided fascial plane block technique targeting the superior gluteal nerve in the plane between gluteus medius/gluteus minimus to treat moderate-to-severe, chronic, refractory greater trochanteric pain syndrome; 2) anatomically correlate the procedure with cadaveric dissections demonstrating the structures being imaged and the tissues along the needle trajectory; 3) demonstrate the feasibility of the technique with serial dissection of one cadaveric specimen following injection with color dye. Technique description The ultrasound-guided fascial plane block targeting the superior gluteal nerve to treat moderate-to-severe, chronic, refractory greater trochanteric pain syndrome has been outlined with supporting ultrasound scans and anatomical dissections. The cadaveric dissections are correlated to the ultrasound scans of a healthy volunteer and provide visualization of the tissues in the needle trajectory. The feasibility study in a cadaveric specimen showed adequate stain of the superior gluteal nerve without spread to the piriformis muscle belly, the sciatic nerve, or the inferior gluteal nerve. Conclusions This ultrasound-guided fascial plane block is a feasible option for blocking the superior gluteal nerve without inadvertent involvement of the sciatic and inferior gluteal nerves. Further randomized controlled clinical trials are necessary to assess the clinical efficacy of the gluteus medius/gluteus minimus fascial plane block to treat moderate-to-severe, chronic, refractory greater trochanteric pain syndrome.
Product characteristics should be reported in all biological therapy publications
Buchheit, Thomas Edward , Hunt, Christine , Eldrige, Jason S. , Eshraghi, Yashar , Souza, Dmitri , Buchheit, Thomas , Eldrige, Jason, Hunt, Christine

Mayo Clinic

Regional Anesthesia & Pain Medicine | March 22, 2022 | Volume: 47 | Issue: 7 | Pages: 449.1-449

10.1136/rapm-2022-103557 | PMID 35318261 Get It

Comparative Effectiveness of Landmark-guided Greater Occipital Nerve (GON) Block at the Superior Nuchal Line Versus Ultrasound-guided GON Block at the Level of C2
Kissoon, Narayan R., O’Brien, Travis G., Bendel, Markus A., Eldrige, Jason S., Hagedorn, Jonathan M., Mauck, William D., Moeschler, Susan M., Olatoye, Oludare O., Pittelkow, Thomas P., Watson, James C., Pingree, Matthew J., Kissoon, Narayan R., O’Brien, Travis G., Bendel, Markus A., Eldrige, Jason S., Hagedorn, Jonathan M., Mauck, William D., Moeschler, Susan M., Olatoye, Oludare O., Pittelkow, Thomas P., Watson, James C., Pingree, Matthew J.

Mayo Clinic

The Clinical Journal of Pain | February 8, 2022 | Volume: 38 | Issue: 4 | Pages: 271-278

10.1097/ajp.0000000000001023 | PMID 35132029 Get It

Objectives: The purpose of this single center, prospective randomized controlled trial was to compare clinical outcomes between an ultrasound-guided greater occipital nerve block (GONB) at the C2 vertebral level versus landmark-based GONB at the superior nuchal line. Methods: Patients with occipital neuralgia or cervicogenic headache were randomized to receive either a landmark-based GONB with sham ultrasound at the superior nuchal line or ultrasound-guided GONB at the C2 vertebral level with blinding of patients and data analysis investigators. Clinical outcomes were assessed at 30 minutes, 2 weeks, and 4 weeks postinjection. Results: Thirty-two patients were recruited with 16 participants in each group. Despite randomization, the ultrasound-guided GONB group reported higher numeric rating scale (NRS) scores at baseline. Those in the ultrasound-guided GONB group had a significant decrease in NRS from baseline compared with the landmark-based GONB group at 30 minutes (change of NRS of 4.0 vs. 2.0) and 4-week time points (change of NRS of 2.5 vs. −0.5). Both groups were found to have significant decreases in Headache Impact Test-6. The ultrasound-guided GONB had significant improvements in NRS, severe headache days, and analgesic use at 4 weeks when compared with baseline. No serious adverse events occurred in either group. Conclusions: Ultrasound-guided GONBs may provide superior pain reduction at 4 weeks when compared with landmark-based GONBs for patients with occipital neuralgia or cervicogenic headache.
Response to ‘An alternative method of establishing the first rib under ultrasound-guidance’
Hurdle, Mark Friedrich B., Ferreira‐Dos‐Santos, Guilherme , Rosario‐Concepción, Raúl A. , Gil, Laura V, Eldrige, Jason S. , Clendenen, Steven R. , Rosario-Concepcion, Raul, Clendenen, Steven R , Rosario-Concepcion, Raul A , Gil, Laura Velez

Mayo Clinic

Regional Anesthesia & Pain Medicine | November 8, 2021 | Volume: 47 | Issue: 4 | Pages: 273.2-273

10.1136/rapm-2021-103254 | PMID 34750165 Get It

Ultrasound-Guided Diagnostic IPACK as a Valuable Tool in the Management of a Patient with Soleal Sling Syndrome: A Doubly Rare Case Report
Clendenen, Steven R. , Ferreira‐Dos‐Santos, Guilherme , Hurdle, Mark Friedrich B., Tran, John , Eldrige, Jason S. , Murray, Peter M. , B Hurdle, Mark Friedrich, Agur, Anne Maria Reet

Mayo Clinic

Pain Management | July 21, 2021 | Volume: 12 | Issue: 1 | Pages: 5-12

10.2217/pmt-2020-0104 | PMID 34284601 Get It

Characterizing the need for multiple epidural blood patches in the treatment of postdural puncture headache: an observational study
Barman, Ross , Kurian, Emil B., Eldrige, Jason S. , Frank, Ryan D. , Garza, Ivan , Whealy, Mark , Cutsforth‐Gregory, Jeremy K. , Olatoye, Oludare, Mustafa, Rafid , Barman, Ross A , Eldrige, Jason, Frank, Ryan, Whealy, Mark A , Olatoye, Oludare , Kissoon, Narayan

Mayo Clinic

Regional Anesthesia & Pain Medicine | May 5, 2021 | Volume: 46 | Issue: 12 | Pages: 1110-1112

10.1136/rapm-2021-102692 | PMID 33952685 Get It

Ultrasound-guided transversus abdominis plane block vs trigger point injections for chronic abdominal wall pain: a randomized clinical trial
Moeschler, Susan M. , Pollard, E. Morgan, Pingree, Matthew J. , Bendel, Mark A., Mauck, William D. , Watson, James C. , Eldrige, Jason S. , Loftus, Conor G., Hooten, W. Michael , Mauck, W David, Pittelkow, Thomas P.

Mayo Clinic

Pain | January 14, 2021 | Volume: 162 | Issue: 6 | Pages: 1800-1805

10.1097/j.pain.0000000000002181 | PMID 33433147 Get It

Abstract The primary aim of this randomized clinical trial is to investigate the effects of ultrasound-guided transversus abdominis plane (TAP) vs ultrasound-guided trigger point injections (TPIs) on numerical rating scale pain scores at month 3 follow-up in patients with a chronic abdominal wall pain. The primary outcome measure was the difference in mean numeric rating scale pain scores between the TAP and TPI groups at month 3 in an intent-to-treat (ITT) analysis. A total of 60 patients were randomized 1:1 to receive an ultrasound-guided TAP block (n = 30) or an ultrasound-guided TPI (n = 30). No significant group differences in baseline demographic or clinical characteristics were observed. The mean baseline pain score for the TAP and TPI groups was 5.5 and 4.7, respectively. In the ITT analysis at month 3, the between-group difference in pain scores was 1.7 (95% confidence interval, 0.3-3.0) favoring the TPI group. In a secondary per-protocol analysis, the between-group difference in pain scores was 1.8 (95% confidence interval, 0.4-3.2) favoring the TPI group. For the ITT and per-protocol analyses, the group differences in pain scores were consistent with a medium effect size. The main finding of this randomized clinical trial is that adults with chronic abdominal wall pain who received a TPI reported significantly lower pain scores at month 3 follow-up compared with patients who received a TAP block.
Counting ribs and thoracic levels under ultrasound: a systematized technical protocol for both posterior and anterior approaches
Hurdle, Mark Friedrich B., Rosario‐Concepción, Raúl A. , Gil, Laura Velez , Eldrige, Jason S. , Clendenen, Steven R. , Rosario-Concepcion, Raul, Gil, Laura V, Clendenen, Steven R , Rosario-Concepcion, Raul A , Ferreira‐Dos‐Santos, Guilherme

Mayo Clinic

Regional Anesthesia & Pain Medicine | January 5, 2021 | Volume: 46 | Issue: 5 | Pages: 452-454

10.1136/rapm-2020-102050 | PMID 33402417 Get It

Over the last two decades, the clinical applications of diagnostic and interventional ultrasound have expanded rapidly. When analyzing the chest wall and thoracic region, ultrasound has previously been shown to reliably identify chest wall pathologies like rib fracture and slipping rib syndrome, as well as having fundamentally changed perioperative management and patient outcomes after the emergence of point-of-care ultrasound. In addition, ultrasound guidance has recently become more popular for multiple blocks in the field of regional anesthesia and pain medicine. In this technical report, we systematize an ultrasound-guided protocol for counting ribs and thoracic levels for both posterior and anterior approaches, which does not require level confirmation by fluoroscopy. With this protocol, we hope to create an effective educational resource to support physicians from any specialty background as they engage in point-of-care ultrasound applications in the thoracic region.
Peripheral Nerve Stimulation and Clinical Outcomes: A Retrospective Case Series
Warner, Nafisseh S. , Schaefer, Kalli K., Eldrige, Jason S. , Lamer, Tim J. , Pingree, Matthew J. , Bendel, Markus A. , Warner, Matthew A. , Rho, Richard H., Mauck, William D. , Warner, Matthew A , Warner, Nafisseh

Mayo Clinic

Pain Practice | November 22, 2020 | Volume: 21 | Issue: 4 | Pages: 411-418

10.1111/papr.12968 | PMID 33222402 Get It

Abstract Purpose Peripheral nerve stimulation (PNS) is a rapidly expanding field within neuromodulation; however, there is limited data on therapeutic efficacy. This study describes the indications and clinical outcomes for patients undergoing PNS for chronic pain states. Patients and Methods This is a retrospective case series of adults undergoing PNS implantation from 2004 to 2017 at an academic medical center. The primary outcomes were changes in numeric rating scale (NRS) pain scores, opioid utilization in oral morphine milligram equivalent (MME), and self‐reported patient functioning at 6 months postoperatively. Infectious and device‐related complications were also assessed. Results A total of 72 patients underwent PNS implantation, including 59 patients that received a preceding PNS trial (59/78; 76% progression rate) and 13 that did not receive a PNS trial. The most common indication for stimulation was occipital neuralgia (47%) followed by lower‐extremity neuropathies (17%). PNS implantation was associated with 6‐month reductions in pain scores (7 [6, 8] baseline vs. 4 [2, 5] 6 months; P < 0.001) and opioid utilization (eg, median 60 [31, 104] vs. 18 [0, 52] MME among those with baseline opioid use; P < 0.001). Median functional improvement was 73% (50%, 88%). Seven patients (10%) suffered a postoperative surgical site infection at a median of 50 (30, 124) days, of which five devices were removed. Conclusion Peripheral nerve stimulation was associated with reduced pain scores, lower opioid utilization, and improved patient function at 6 months. These data support PNS as a potentially effective nonopioid analgesic modality in chronic pain, though prospective multicenter evaluation is warranted to evaluate longer‐term outcomes.
Peri‐procedural Management of Implanted Spinal Cord Stimulators in Patients Undergoing Radiofrequency Ablation: A Case Report and Manufacturer‐Specific Recommendations
Abdullah, Newaj , Muir, Casey , Eldrige, Jason S. , Pingree, Matthew J. , Hagedorn, Jonathan M. , Hagedorn, Jonathan M

Mayo Clinic

Pain Practice | November 20, 2019 | Volume: 20 | Issue: 4 | Pages: 405-411

10.1111/papr.12860 | PMID 31746540 Get It

Abstract IntroductionRadiofrequency ablation (RFA) and spinal cord stimulation (SCS) are 2 common modalities used in management of various pain conditions. RFA generates heat and an electromagnetic field that can theoretically interfere with the functionality and longevity of the SCS device. This is problematic for patients who need RFA and have previously undergone implantation of an SCS device.Case DescriptionWe present a case highlighting the safe use of bipolar RFA in a patient who had previously undergone implantation of a cervical SCS device.DiscussionWe also present device‐specific industry guidelines and recommendations for performing RFA in patients following SCS device implantation.